Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

Clinical NGS Data Analysis Software - NGeneAnalySys

● Product Introduction - NGeneAnalySysTM


NGeneBio clinical NGS analysis SW platform. 

It provides accurate pathogenic variants information based on ACMG guideline and relevant therapy information based on databases (solid tumor / hematologic malignancies), which enables efficient on-site data analysis for clinical NGS.


  • Clinical SW for NGS diagnostics 
  • GMP/ISO13485 certified 
  • Korea MFDS IVD (KFDA class II) approved (Dec/2017); 
  • combined with BRCAaccuTest
  • CE-IVD marked (Jun/2017)
  • Integrated DBs for clinical significance & relevant drug information provided 



● Features

Advanced analytical platform

  • Compliance with ACMG guideline for NGS clinical use
  • Provides tier-based reporting with therapeutic drug information and clinical trials
  • Detected variants list with detailed information and visual charts

Accurate interpretation

: Recent databases employed and In Silico prediction

  • Reference sequence DB
  • Population DB
  • Cancer specific DB
  • Constitutional variant DB
  • Internal DB

Create Report

  • Provides QC report on sample data and clinical report of variants analysis

Easy analysis

  • From data uploading to analysis result by one UI operation



  • NGeneAnalysys V.1.1 is compatible with NGeneBio BRCAaccuTest
  • NGeneAnalysys V.1.3 is compatible with NGeneBio all clinical NGS kits (BRCAaccuTest/BRCAaccuTestPLUS/SOLIDaccuTest/HEMEaccuTest) and Illumina TruSight Tumor 170